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This study compares in vitro and in vivomodels of lipid digestion from almond particles within a complex
food matrix (muffins) investigating whether the cell-wall barrier regulates the bioaccessibility of nutri-
ents within this matrix. Muffins containing small (AF) or large (AP) particles of almond were digested
in triplicate using an in vitro dynamic gastric model (DGM, 1 h) followed by a static duodenal digestion
(8 h). AF muffins had 97.1 ± 1.7% of their lipid digested, whereas AP muffins had 57.6 ± 1.1% digested. In
vivo digestion of these muffins by an ileostomy volunteer (0–10 h) gave similar results with 96.5% and
56.5% lipid digested, respectively. The AF muffins produced a higher postprandial triacylglycerol iAUC
response (by 61%) than the AP muffins. Microstructural analysis showed that some lipid remained encap-
sulated within the plant tissue throughout digestion. The cell-wall barrier mechanism is the main factor
in regulating lipid bioaccessibility from almond particles.
 2017 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
It is well established that intact cell walls play an important role
in regulating the bioaccessibility of intracellular lipid and other
nutrients in almond seeds (Ellis et al., 2004; Mandalari et al.,
2008). In this paper, we refer to bioaccessibility as the proportion
of a nutrient or phytochemical compound ‘released’ from a com-
plex food matrix during digestion and, therefore, potentially avail-
able for absorption in the gastrointestinal (GI) tract.Despite the high lipid content of almonds (typically in the range
of 50–55%), a meta-analysis of randomized controlled trials indi-
cates that their consumption does not result in increased body
weight or BMI (Flores-Mateo, Rojas-Rueda, Basora, Ros, & Salas-
Salvadó, 2013), and this is believed to be, in part, due to their
low lipid bioaccessibility. Novotny et al. estimated that only 76%
of the energy contained within almonds (based on the Atwater fac-
tors) is actually metabolized (Novotny, Gebauer, & Baer, 2012).
Accumulating evidence suggests that the limited bioaccessibility
of lipids within intact almond tissue can be attributed to the struc-
tural integrity of almond cell walls, which protect encapsulated
lipids from digestion during passage through the GI tract. We have
demonstrated that mastication of whole natural almonds released
only a small proportion (7.8%) of the total lipid (Mandalari et al.,
2014). However, the overall release/digestion of lipid increased
during subsequent simulated gastric (16.4%) and duodenal
(32.2%) digestion, with 67.8% of the lipid remaining undigested
(Mandalari et al., 2014). The lipid release frommasticated almonds
was in close agreement with that predicted by a theoretical model
for almond lipid bioaccessibility, which had particle size and cell
diameter as variables (Grassby et al., 2014; Grundy, Grassby
Table 1
Ingredients for each almond muffin.
Ingredients Weight (g)
Cornflour 10.6
Wheat flour (white, plain) 25.0
Sugar (white) 32.6
Baking powder 2.3
Skimmed milk 54.6
Egg white 5.7
Vanilla flavoring 4.4
Almonda 85.0
Total 220.2
a Almond was in the form of almond flour (AF,
<450 mm) or almond particles (AP, 1700–2000 mm).
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particle size (i.e. proportion of intact cells) resulted in an increased
rate and extent of lipolysis in an in vitro model of duodenal diges-
tion (Grundy, Wilde, Butterworth, Gray, & Ellis, 2015). All these
studies provide convincing evidence that the preservation of the
structural integrity of almonds during digestive transit is the major
factor responsible for the limited lipid bioaccessibility of almonds.
In addition to effects on energy balance, this may influence chronic
and postprandial metabolic factors relating to cardio metabolic
disease risk factors (Estruch et al., 2013). Indeed, a randomized
crossover dietary-intervention study by Berry et al. (2008) showed
that ingestion of muffins containing almond macroparticles (1.7–
3.4 mm, in which 95% of the lipid was encapsulated by cell walls)
resulted in lower postprandial lipemia (an independent risk factor
for cardiovascular disease (CVD)) (Bansal et al., 2007; Lindman,
Veierød, Tverdal, Pedersen, & Selmer, 2010; Nordestgaard, Benn,
Schnohr, & Tybjærg-Hansen, 2007), compared with a
nutritionally-matched muffin containing defatted almond flour
and extracted free lipid (i.e. no lipid encapsulation). However, muf-
fins containing defatted almond flour are unrealistic, so we have
used muffins containing almond flour and almond particles in this
study. Muffins represent a good processed food model, as they con-
tain moisture, lipid, protein and carbohydrates, which may interact
with the almonds during processing, and their production involves
a number of commonly occurring processes.
The aim of the present study was to assess and compare lipid
bioaccessibility from test meals containing almonds of different
particle sizes (degrees of lipid encapsulation) in a dynamic
in vitro digestion model and post-digestion in an ileostomy volun-
teer. This comparison is important for the validation of the
dynamic gastric model (DGM) of digestion in determining its use-
fulness to assess the digestibility of nutrients within complex food
matrices. To the best of our knowledge, this is the first investiga-
tion directly comparing the digestion of meals with a complex
matrix in both the DGM and in vivo.2. Materials and methods
2.1. Test meals
The test meals consisted of an almond muffin (220 g) served
with custard (80 g, Bird’s Low Fat Instant Custard; Premier Ambi-
ent Products, Lincolnshire, UK). Natural (raw) almond kernels or
seeds (Amygdalus communis L.; variety Nonpareil) were produced
by Hughson Nut Inc. (Hughson, CA 95326, USA) and supplied by
the Almond Board of California (Modesto, CA 95354, USA).
Almonds were ground in a coffee grinder (Lloytron PLC, Lancashire,
UK) and sieved to produce almond macroparticles (AP, particle size
range 1700–2000 mm) and almond flour (AF, particle size
<450 mm). The predicted lipid bioaccessibility values of the AF
and AP were 49% and 6%, respectively (Grassby et al., 2014). The
muffins were prepared from the ingredients listed in Table 1, with
each muffin containing 85 g of almond as either AF or AP. In brief,
the dry ingredients were thoroughly mixed by sifting them
together twice, and then the wet ingredients were combined in a
separate bowl, to which the dry mixture was gently incorporated.
The muffin mixture was baked (using a domestic, fan-assisted
oven) in muffin cases at 180 C for 20 min, followed by 13 min at
200 C, with the muffins protected by foil for the final 3 min. Muf-
fins were baked in a single batch, cooled to ambient temperature,
and then frozen until needed (20 C). The test meals included
custard (prepared using the manufacturer’s instructions) to
encourage the volunteers to swallow without significant mastica-
tion in order to minimize further particle size reduction. Both muf-
fins had identical nutrient contents as calculated from theingredients in Table 1 and nutrition tables (Food Standards
Agency, 2002), except lipid which was measured by Soxhlet anal-
ysis (hexane): 48 g of lipid, 25 g of protein, 79 g of available carbo-
hydrate (starch and sugars) and 10 g of dietary fiber. The total
energy content of each muffin was 742 kcal (3161 kJ). The nutri-
tional contribution of 80 g of custard was 1.4 g of fat, 0.5 g of pro-
tein, 9.5 g of carbohydrate and 0.1 g of dietary fiber.
2.2. Simulated digestion
For the in vitro digestion, human mastication was followed by
digestion within the dynamic gastric model (DGM) and a static
duodenal model. The DGM provides a realistic simulation of the
physical and chemical processes within the human stomach, and
accurately mimics the transit time and luminal environment
(Mandalari et al., 2013; Pitino et al., 2010). This method allows
sampling at pre-determined times throughout gastric and duode-
nal digestion.
2.2.1. Mastication of almond muffins for simulated digestion
A healthy volunteer was recruited by the Human Nutrition Unit
at the Institute of Food Research (IFR) for a series of 8 study days
(between November 2013 and February 2014), four for each muffin
type, AF or AP. Only one volunteer was used to improve repro-
ducibility between replicates. In previous studies, we found that
the particle size distribution of masticated almonds is generally
consistent across individuals, so this volunteer is likely to be repre-
sentative of the general population (Grundy, Grassby et al., 2015).
The inclusion and exclusion criteria have been reported previously
(Grundy, Grassby et al., 2015). The mastication study received NHS
ethics committee approval (10/H0717/096) and informed consent
was obtained from the participant. The study was conducted in
accordance with the ethical standards laid down in the 1964 Dec-
laration of Helsinki and its later amendments. The study was reg-
istered at the ISRCTN registry (ISRCTN58438021). On each study
day the volunteer was asked to masticate half a muffin (110 g)
and custard (40 g) and expectorate each mouthful when they felt
the urge to swallow. Each frozen muffin was cut vertically in half;
one half was defrosted at 4 C the day before the study day, the
remaining half was kept frozen (-20 C) until needed. Mastication
of the test meals took 3 min 22 s and 6 min 38 s on average for
the AF and AP muffins, respectively. During mastication, the volun-
teer produced 21.8 g ± 4.2 and 35.8 g ± 3.3 of saliva for the AF and
AP muffins, respectively.
2.2.2. Gastric digestion
Individual masticated AF (n = 3) or AP (n = 3) muffin samples
(180 g each) were fed into the DGM for 63 min in the presence
of priming acid (20 ml), whose composition has been reported pre-
viously (Pitino et al., 2010). The digestion time was calculated by
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chemical properties of the meal (Thuenemann, Mandalari, Rich, &
Faulks, 2015). The composition of the simulated gastric acid solu-
tion has been reported previously (Mandalari et al., 2014). The sim-
ulated gastric enzyme solution was prepared by dissolving porcine
gastric mucosa pepsin and a gastric lipase analogue from Rhizopus
oryzae in the above described salt mixture (no acid) at a final con-
centration of 9000 U mL1 and 60 U mL1 for pepsin and lipase,
respectively. A suspension of single-shelled lecithin liposomes,
prepared as previously described (Mandalari et al., 2008) was
added to the gastric enzyme solution at a final concentration of
0.127 mM. A total of seven samples (35 g) were removed from
the DGM at 9 min intervals (63 min total digestion time). The
amounts of acid secretions (means ± SD) added during gastric
digestion were 28 mL ± 3 and 21 mL ± 2 for AF and AP muffins,
respectively. The amounts of gastric enzymes (means ± SD) added
during gastric digestion were 28 mL ± 2 and 29 mL ± 4 for AF and
AP muffins, respectively. A control run without addition of gastric
enzymes was performed for both AF and AP muffins: the amount of
acid secretion added during gastric digestion was 34.6 mL for AF
and 26.3 mL for AP. Each gastric sample was weighed, its pH
recorded and adjusted to 7.0 with NaOH (1 M) to inhibit gastric
enzyme activity.
2.2.3. Duodenal digestion
A pooled sample (42 g), obtained from an aliquot (6 g) of each
gastric sample, was transferred to a Sterilin plastic tube for duode-
nal digestion with the addition of simulated bile solution (10.4 mL)
and pancreatic enzyme solution (29.2 mL) and incubated at 37 C
under shaking conditions (170 rpm) for 8 h. Aliquots (10 g at 1–
6 h, 15 g at 7 and 8 h) were taken every hour during duodenal incu-
bation and replaced with fresh bile (1.2 mL) and pancreatic
enzymes (3.5 mL).
Simulated bile was prepared fresh daily. It contained lecithin
(6.5 mM), cholesterol (4 mM), sodium taurocholate (12.5 mM),
and sodium glycodeoxycholate (12.5 mM) in a solution containing
NaCl (146.0 mM), CaCl2 (2.6 mM), and KCl (4.8 mM). Pancreatic
enzyme solution contained NaCl (125.0 mM), CaCl2 (0.6 mM),
MgCl2 (0.3 mM), and ZnSO47H2O (4.1 lM). Porcine pancreatic
lipase (590 U mL1), porcine colipase (3.2 lg mL1), porcine tryp-
sin (11 U mL1), bovine a-chymotrypsin (24 U mL1), and porcine
a-amylase (300 U mL1) were added to the pancreatic solution.
All samples were immediately frozen and retained for analyses.
2.2.4. Lipid release determination
Almond muffin test meals (AF and AP), post-mastication sam-
ples and digesta residues recovered during simulated gastric and
duodenal incubation were analyzed for lipid content. The post-
mastication samples and digesta residues were centrifuged
(3800  g, 15 min) prior to analysis to remove the liquid phase.
The pellet was then dried and analyzed. Lipid extraction was per-
formed using a Soxhlet extraction method with n-hexane as sol-
vent (Association of American Cereal Chemists [AOAC], 1995).
Lipid release was the total lipid in the muffin minus the lipid con-
tent of the residue on a dry weight basis.
2.2.5. Microstructural analysis
Microstructural analysis of the almond muffin test meals (AF
and AP), post-mastication samples and simulated digestion ali-
quots was performed as previously reported (Grundy, Grassby
et al., 2015). Briefly, aliquots of AP muffin samples were transferred
to vials containing the fixative (2.5% v/v glutaraldehyde) for
2 weeks, followed by post-fixing in 2% (w/v) osmium tetroxide. A
graded ethanol series was used to dehydrate the samples, before
infusion with propylene oxide, and embedding in Spurr resin. Thin
(70 nm) sections and semi-thin (1 mm) sections were cut using aDiatome diamond knife (Leica Microsystems Ltd). The thin sections
were then examined using a Tecnai T12 transmission electron
microscope (FEI Europe) and AMT camera system. Aliquots of AF
muffin samples were directly placed on a microscopy slide and
stained with Nile red to highlight lipid (Zeiss Axioskop 2 mot plus
microscope, excitation at 510–560 nm, emission at 590 nm).
2.3. Ileostomy digestion
For the in vivo digestion, volunteers with an ileostomy were
asked to eat the test meals. Ileal effluent from the volunteers was
collected for lipid content measurements along with postprandial
blood samples to determine lipemia and glycemia. Despite the
major changes occurring to the morphology of the GI tract follow-
ing an ileostomy, the ileostomy model has been widely used in
studies of resistant starch (Champ, Langkilde, Brouns, Kettlitz, &
Le Bail-Collet, 2003). Since the majority of nutrient absorption
takes place in the upper GI tract, the effluent recovered at the ter-
minal ileum (via the stoma) is considered to be representative of
human digestion, although there is some evidence that gastric
emptying time and terminal ileum bacterial counts may be higher
in ileostomy subjects than in healthy subjects (Booijink et al.,
2010; Robertson & Mathers, 2000). Despite these differences, the
alternative method of intubation was rejected as being unlikely
to give representative samples.
2.3.1. Study design
A single-blind (researcher-blind), randomized, cross-over study
design was used where the participants were randomly allocated
to receive the AF or AP muffinmeal using a computer generated list
of random numbers. The randomization, enrolment and allocation
of participants were done by the study investigators. The differ-
ence in texture between the interventions meant the subjects were
not blinded, but samples were coded so those investigators assess-
ing outcomes were blinded. Sample size calculations, using G-
Power 3.1.2, were based on 9 participants completing the study
at 80% power and an a-level of 0.05 to detect a 235 mmol min L1
in TAG iAUC difference with an SD of differences of
221 mmol min L1 using data from Berry et al. (2008). The primary
outcomes were serum TAG concentrations (iAUC) and ileal effluent
lipid content; all other outcomes were secondary or exploratory.
2.3.2. Subjects
This study had participant recruitment and screening in com-
mon with the study described by Edwards et al., with the aim of
recruiting 8–10 healthy participants with ileostomies (Edwards
et al., 2015). The participants were eligible if they had undergone
a proctocolectomy for ulcerative colitis, lower bowel cancer or
pure colonic Crohn’s disease and had normal stoma function for
at least one year previously. Other inclusion criteria included: no
allergy to almonds or other test meal ingredients; no previous
obstruction of the stoma; BMI in the range 20–35 kg m2; no
mouth, throat or GI problem (other than ileostomy); total serum
cholesterol <7.8 mmol L1; serum triacylglycerol (TAG)
<3 mmol L1; plasma glucose <7 mmol L1; and liver function
and blood cell counts within prescribed limits. These were
assessed using a screening questionnaire and full medical exami-
nation. All screening and study visits took place at the Clinical
Research Facility at St Thomas’ Hospital, London, UK between
November 2012 and April 2013. The stopping guidelines for this
study included clinical review of any participant who experienced
adverse events (such as blockages), and discussion within the
study team as to whether that adverse event posed sufficient risk
to future participants to warrant early termination of the study.
The study received NHS ethics committee approval (12/LO/1016)
and informed consent was obtained from all participants. The
266 T. Grassby et al. / Journal of Functional Foods 37 (2017) 263–271study was conducted in accordance with the ethical standards laid
down in the 1964 Declaration of Helsinki and its later amend-
ments. The study was registered at the ISRCTN registry
(ISRCTN40517475).2.3.3. Study day
Following screening, participants were asked to attend two
separate study days with a gap of at least one week between vis-
its. Prior to each study day, each participant was advised to fast
(except water) from 8 pm having consumed a low fat (9.1 g fat),
low fiber (5.2 g fiber) evening meal. On the study day, partici-
pants changed their stoma bag and were cannulated in a forearm
vein. Baseline blood samples were collected before the partici-
pants were given the test meal (220 g AF or AP muffin, plus
80 g of custard) for breakfast, which they were asked to consume
within 15 min. The nutritional content of the meals as eaten was:
49.4 g lipid, 25.5 g protein, 88.5 g available carbohydrate and
10.1 g dietary fiber. Lunch (low fat yoghurt and a banana) and
dinner (6.5 g fat) were provided 4 h and 10 h after breakfast,
respectively. Water was freely available throughout the day. The
lunch was given to make the procedure acceptable to volunteers
and provided minimal lipid (0.7 g) and dietary fiber (2.7 g non
starch polysaccharides) and has previously been shown to have
no effect on the postprandial lipemic response (Berry et al.,
2008). Values for the lunch food items were obtained from UK
Food tables (FSA, 2002). All lipid derived from food consumed
during each visit, apart from the test meals, was readily available
for absorption, and therefore assumed to be absent from the col-
lected effluent.2.3.4. Blood samples
Blood samples were collected at baseline and at 15, 30, 45, 60,
90, 120, 150, 180 and 240 min after breakfast for analysis of plasma
glucose, insulin and C-peptide, and serum TAG and non-esterified
fatty acids (NEFA). Additional samples were collected at 5, 6, 7,
and 8 h after breakfast for analysis of serum TAG and NEFA. All
samples were collected and stored as described by Edwards et al.
(2015).
Glucose (glucose oxidase ILTestTM kit), TAG (triglycerides ILTestTM
kit) and NEFA (Randox NEFA kit) concentrations were measured
using colorimetric assays on an ILab 650 auto-analyzer. Insulin,
C-peptide and gut hormones (glucose-dependent insulinotropic
polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and polypep-
tide YY (PYY)) were analyzed according to Filippou, Berry,
Baumgartner, Mensink, and Sanders (2014). Cholecystokinin
(CCK) was analyzed by the method described in Edwards et al.
(2015). Incremental area under the curve (iAUC) values were calcu-
lated in Excel 2007 using the trapezoid rule for TAG (480 min), glu-
cose, insulin and C-peptide (120 min).2.3.5. Analysis of ileal effluent
Effluent samples were collected by the participants, by transfer-
ring the contents of their stoma bag to the sample bags at 2 h inter-
vals for 10 h, and then at the participants’ convenience for a further
16 h. Effluent was weighed and frozen at 20 C immediately on
collection, and then transferred to 80 C within 8 h. Moisture
content was measured by freeze-drying the samples (50 g). These
were then ground up prior to Soxhlet extraction in n-hexane to
determine lipid content in duplicate. It was assumed that all lipid
released from the muffinmatrix was digested and absorbed in vivo;
therefore lipid digestion is equivalent to the total starting lipid in
the muffin minus the lipid content of the ileal effluent. Aliquots
of the effluent were collected at each time point and prepared
for microscopy as described above.2.4. Statistical analysis
Data from the in vitro digestion were analyzed using SPSS ver-
sion 17.0. For all tests, the significance level was set at P < 0.05 (2
tailed). All data are expressed as means ± SEM. Repeated-
measures ANOVA was used to test for differences in lipid release
after mastication, gastric and duodenal digestion with muffin type
as a ‘within-sample’ factor. Differences in lipid release between the
AF and APmuffin samples were analyzed by Student’s paired t-test.3. Results
3.1. Total lipid release during mastication and simulated digestion
The cumulative release of lipid, as a percentage of the original
lipid present in each muffin, after mastication, in vitro gastric and
gastric plus duodenal digestion is reported in Table 2. As expected,
the total lipid released was significantly (P < 0.005) higher for the
AF (97.1 ± 1.7%) muffin than the AP muffin (57.6 ± 1.1%).
Repeated-measures ANOVA showed that the differences in lipid
release between the different stages of digestion were significant
(P < 0.001). For the AF muffin, an increase in lipid release was
observed during the gastric phase compared with that detected
in the masticated samples. In accordance with our previous inves-
tigation (Mandalari et al., 2014), duodenal digestion produced a
significant increase in lipid release over and above that of the gas-
tric phase alone, for both meals. The ‘‘blank” runs, that did not
include digestive enzymes, had total lipid release values of 16.1%
and 2.2% from the AF and AP muffins, respectively.
3.2. Lipid digestion in vivo
After the first participant completed both study days without
any adverse events, two participants experienced temporary
obstruction of the stoma following ingestion of their first test meal,
leading to termination of the study on ethical grounds (see CON-
SORT diagram, Supplementary Fig. 1 in supplementary informa-
tion). Data is therefore shown for the one completed volunteer
only.
The effluent collections were analyzed for dry matter and lipid
content, which are presented in Table 3. Results for 0–10 h are
reported for comparison to the in vitro data, but as almond parti-
cles were still being recovered the morning after the study day,
0–24 h data are also shown. The lipid digested after ingestion of
AF and AP muffins, over 0–10 h was 96.5% and 56.5%, respectively.
The undigested lipid recovered in the effluent at each time point, as
a proportion of that ingested in the muffin (48 g), is presented in
Fig. 1A, showing clear differences between the test meals. The ileal
effluent recovered 2 h after consumption of the AF muffin had the
second highest undigested lipid content for that meal (1.3% lipid);
which may indicate that 2 h is insufficient time to fully digest the
accessible lipid (i.e. mainly from fractured almond cells). For the AP
meal, the effluent recovered after 12 h had the highest undigested
lipid content (17.0%). The dry matter content of the ileal effluent
for each time point is presented in Fig. 1B. Overall, more dry matter
was excreted after consumption of the AP muffin compared with
the AF muffin. A significant portion of the former was recovered
at 12 h, which may indicate that the evening meal pushed through
any almond particles remaining in the stomach.
3.3. Effects of mastication and digestion on almond microstructure
During sample processing, almond particles could be easily
identified by eye in the effluent obtained from the chewing and
digestion of both test meals.
Table 2
Total lipid release (%) from muffins containing almond flour (AF, n = 3) or almond
particles (AP, n = 3) after mastication, in vitro gastric and gastric plus duodenal
digestion (total digestion time was 9 h). Values are presented as means ± SEM.
AF AP
Lipid released after mastication (%) 4.4 ± 0.4 1.9 ± 0.2
Lipid released after gastric digestion (%) 41.6 ± 1.6 5.8 ± 0.1
Lipid released after gastric plus duodenal
digestion (%)
97.1 ± 1.7 57.6 ± 1.1
Recovered lipid (%) 2.9 ± 1.7 42.4 ± 1.1
Total lipid released is calculated relative to the lipid content of the muffin (24 g of
lipid).
Repeated-measures ANOVA showed that the differences in lipid release between
the different stages of digestion were significant (P < 0.001).
Total lipid released was significantly (P < 0.005) higher for the AF muffin than the
AP muffin.
AF, muffin containing almond macroparticles.
AP, muffin containing almond flour.
Table 3
Characteristics of ileal effluents after ingestion of muffins containing almond flour
(AF) or almond particles (AP) over 0–10 h or 0–24 h. (n = 1).
AF AP
Total weight, 0–10 h (g) 465.8 423.9
Total dry matter, 0–10 h (g) 42.2 47.4
Total lipid content, 0–10 h (g) 1.7 20.9
Lipid digested, 0–10 h (%)a 96.5 56.5
Recovered lipid, 0–10 h (%)a 3.5 43.5
Total weight, 0–24 h (g) 672.7 726.9
Total dry matter, 0–24 h (g) 59.0 85.0
Total lipid content, 0–24 h (g) 2.7 29.6
Lipid digested, 0–24 h (%)a 94.4 38.3
Recovered lipid, 0–24 h (%)a 5.6 61.7
a Percentage values calculated as a proportion of the lipid content in the almond
muffins only (i.e. 48 g of lipid). Lipid content was measured in duplicate.
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Fig. 1. Proportion of undigested lipid in the effluent samples (A) and dry matter
content of effluent (B) recovered at each sampling point from the terminal ileum of
the ileostomy volunteer (n = 1) for AF (green) and AP (blue). Lipid values are
calculated as a percentage of the muffin lipid (48 g). Lipid analysis of duplicate
samples. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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Fig. 2. Light micrographs unstained (A1, B1) and stained with Nile red (C1, A2-C2)
of almond particles from AF recovered at different stages of digestion: baseline
muffin (A), after in vitro gastric and duodenal digestion (B), and ileal effluent at 8 h
(C) of digestion. Lipids are stained in red with Nile red. Scale bars: A and B = 20 lm;
C = 50 mm. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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Although the particles were examined at all stages of digestion,
changes to the microstructure of the AF particles (comprising the
lipid-rich cotyledon cells) were only observed after gastric plus
duodenal digestion (Fig. 2A and B). Staining the lipid with Nile
red highlighted the loss of lipid from the cells at the periphery of
the AF particles. Some lipid remained encapsulated in the cells,
in agreement with the biochemical quantification of lipid.
Although it is difficult to evaluate quantitatively, the majority of
the lipid appeared to have coalesced.
These observations were also reflected in the large almond par-
ticles where the lipid had been fixed with osmium tetroxide
(Fig. 3A and E). The lipid within raw almonds is found in oil bodies
(1–3 mm in diameter), but after processing and subsequent diges-
tion they had all coalesced to form large oil droplets (5–35 mm
diameter) (Fig. 3A2 and E2). In some parts of the tissue the cell
walls had fractured (possibly during baking and/or freezing of
the almond muffins), but the cell contents were still largely
trapped within the tissue matrix.
3.3.2. In vivo digestion
The micrographs of almond particles collected after ingestion of
the AF muffin show that there are some particles which still con-
tain encapsulated lipid after 8 h of digestion (Fig. 2C). In fact, there
were some particles that contained encapsulated lipid even after
20 h of digestion (data not shown). However, these particles are
small (<400 mm) and therefore make up a small proportion of the
lipid that was initially present ( 3 mg for each 400 mm particle).
The structural integrity of the particles appeared largely
A2A1
B1 B2
C1 C2
D2D1
E1 E2
F1 F2
Fig. 3. Light micrographs (A1-F1) and TEM micrographs (A2-F2) of sections of
almond particles from AP recovered at different stages of digestion: baseline (pre-
digested) muffin (A), ileal effluents at 2 h (B), 4 h (C), 8 h (D) of digestion, in vitro
post gastric and duodenal digestion (E), and ileal effluent at 12 h (F) of digestion.
Scale bars: A1 – F1 = 100 lm; A2 – F2 = 5 lm.
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as particle erosion, cannot be excluded by microscopy. In both the
in vitro and in vivo digestions some fissures are identifiable in the
micrographs, and the lipid is clearly bioaccessible where these fis-
sures have compromised the cells.Micrographs of the larger particles recovered after ingestion of
the AP muffin, (Fig. 3B–D and F) showed that undigested lipid
remained trapped within the almond particles despite apparent
damage to the cell walls. However, progressive loss of lipid from
the surface of the large particles (Fig. 3F1) suggests that the cell
wall damage made some of the lipid near the surface bioaccessible,
and perhaps that the intact cell walls become less efficient barriers
to digestion with time. While the lipid loss was never complete, it
became more noticeable at the later stages of digestion (>10 h). It
was also noted that some swelling of the almond cell walls, at least
in cells that had lost their contents, seemed to occur as digestion
time increased (Fig. 3F2), in agreement with an earlier study
(Mandalari et al., 2008). The microstructural features of particles
digested for the same period of time in vitro or in vivo appeared
to be similar to each other (i.e. samples recovered at 8 h).
3.4. Postprandial metabolic responses
As results from a single participant are presented, care must be
taken when interpreting the data. However, the results add to the
limited published data from people with an ileostomy and provide
some useful insight into the metabolic responses to the two differ-
ent forms of almond used in the muffins.
3.4.1. Serum lipid concentrations
Changes in postprandial serum TAG concentrations are pre-
sented in Fig. 4. The serum TAG iAUC (480 min) was 61% higher
for AF muffins than AP muffins (148.8 vs 92.3 mmol min L1), with
peak serum TAG at 2.5 h for AF (0.63 mmol L1 greater than fast-
ing) and 4 h for AP (0.42 mmol L1 greater than fasting). Serum
concentrations of NEFA (Supplementary Fig. 2) following ingestion
of AF and AP were lower than the fasting values for the whole 8 h
tested.
3.4.2. Plasma glucose, insulin, C-peptide and gut hormone
concentrations
The iAUC (0–120 min) for postprandial glucose, insulin and C-
peptide responses were 30% (98 vs 140 mmol min L1), 36% (15.0
vs 23.5 nmol min L1) and 30% (112 vs 161 nmol min L1) lower
for AF than AP, respectively. The pattern of the postprandial
responses for all three of these measures were broadly similar
(Supplementary Fig. 2) with a broad peak at 3 h for the AF muffin
(2.0 mmol L1, 0.219 nmol L1 and 1.58 nmol L1, above baseline
respectively) and a sharp peak at 30 min for the AP muffin
(2.8 mmol L1, 0.460 nmol L1 and 2.130 nmol L1, above baseline
respectively). Postprandial GIP, GLP-1, CCK and PYY concentrations
in response to the two test meals had different patterns of response
as shown in Supplementary Fig. 3. The CCK concentrations after
ingestion of the AP meal were considerably reduced below fasting
levels.4. Discussion
Here we have demonstrated, using in vitro and in vivomodels of
digestion, that the bioaccessibility of almond lipid within a com-
plex food matrix is significantly affected by the size of the almond
particles in the food. The testing of the same experimental meals in
both models was originally performed to allow validation of the
in vitro model as a good mimic of human digestion under realistic
physiological conditions. Although only one participant completed
the in vivo study, it was still possible to tentatively compare the
models in terms of the proportion of lipid released from the matrix
and the microstructural changes during digestion, and indeed the
results showed very good agreement for both outcomes. The differ-
ence in total lipid digestibility between the AF and AP muffinmeals
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Fig. 4. Changes from fasting in serum TAG concentrations in an ileostomy volunteer
(n = 1) after the test meals containing 48 g of lipids. AF (green) or AP (blue). (For
interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
T. Grassby et al. / Journal of Functional Foods 37 (2017) 263–271 269obtained with the DGM model (9 h total digestion time) and the
ileostomy volunteer (up to 10 h digestion time) was 40%. The
good agreement between the models could be attributed to our
use of an in vivomastication step, as this step is arguably the hard-
est stage to model in vitro (Minekus et al., 2014). The greater recov-
ery of lipids in ileal effluent following consumption of the AP
muffin compared with the AF meal is consistent with the results
of Cassady, Hollis, Fulford, Considine, and Mattes (2009) who found
increased fecal lipid content when samples were chewed fewer
times (larger average particle size).
The importance of encapsulation of nutrients within intact
cell walls (i.e. a barrier mechanism) has been studied previously
under similar conditions (Grundy, Grassby et al., 2015;
Mandalari et al., 2008), but without incorporation of almonds
into a processed food matrix. An investigation of the postpran-
dial effects of encapsulated vs completely free lipid within a
muffin was recently performed in healthy subjects, which
showed the importance of lipid bioaccessibility for postprandial
lipemia (Berry et al., 2008). The effect of the food matrix on
the absorption of artificially encapsulated fish oil has been
assessed in ileostomy subjects or volunteers, although in this
case the purpose of encapsulation was the prevention of lipid
oxidation (Sanguansri et al., 2013). This present study builds
on our previous work (Berry et al., 2008; Grundy, Grassby
et al., 2015; Mandalari et al., 2008, 2014) by measuring lipid
bioaccessibility from naturally-encapsulated lipid within a food
matrix (muffins), while simultaneously observing the structural
changes within the upper GI tract (with a suitable in vitro
model), and the effect of particle size on postprandial metabolic
responses.
The proportion of lipid digested in the DGM was greater for
both muffin meals than masticated raw and roasted almonds
(32% for both almond types) studied previously (Mandalari
et al., 2014). This may be because the muffin meals were digested
for 9 h with the digestive enzymes replenished at 2 h intervals,
whereas the masticated almonds were digested for only 3 h. The
digestion time was extended for the current study in order to bet-
ter reflect the transit time typically experienced by the ileostomy
volunteer and also that TAG takes longer to appear in the blood-
stream. The form of the digested almonds may have affected the
process as well. In the current study the muffin matrix does not
appear to have impeded lipid bioaccessibility and digestion. The
test muffins consisted of almond particles in a matrix of sucrose,
protein and gelatinized starch, which were probably rapidly
digested and therefore unlikely to have formed a significant barrier
to digestion of the almond lipid. The degree to which the tissue
structure remains intact after pre-ingestion processing andmastication, appears to have a strong effect on the rate and extent
of the lipid digestion.
It is interesting to note that there was limited lipid digestibility
of the AP despite the cell wall damage identified by the microstruc-
tural analysis. One would expect the cell wall damage to allow free
diffusion of digestive enzymes and lipid through the tissue. How-
ever, this exposure of intracellular lipid caused by cell wall rupture
as well as possible lipid molecules present at the interface may
have been offset by the lack of a continuous aqueous phase, since
lipase can only act at the water-lipid interface, facilitated by coli-
pase and bile salts (Grundy et al., 2016). In addition, the coales-
cence of the lipid may have limited the rate of reaction due to
the decreased surface area to volume ratio, although this would
apply to both the AF and AP. The lipid coalescence probably hap-
pened when the muffins were baked, whereas the damage to
almond cell walls may have been caused by mechanical processing
of the almonds and/or freezing the almond muffins prior to diges-
tion. The processing method used to prepare the samples for
microscopy does not seem to result in cell wall damage or lipid
coalescence (Grundy, Grassby et al., 2015).
The recent study by Sanguansri et al. investigated the effect of
incorporating microencapsulated omega-3 long-chain polyunsatu-
rated fatty acids (LCPUFA) into a food matrix on lipid release in the
upper gastrointestinal tract (Sanguansri et al., 2013). Regardless of
whether the oil was supplied as fish oil capsules or as a microen-
capsulated powder incorporated into a food matrix, specifically
orange juice, yoghurt and a cereal bar; only 0.58–0.73% of the total
LCPUFA was recovered in the ileal effluent. In the matrices that
Sanguansri and colleagues used, the oil was only mixed with the
other ingredients to protect the oil during processing, rather than
being an integral part of an intact tissue, which explains why in
our study the encapsulated lipid in the almond tissue was not fully
digested.
The postprandial serum responses of a single subject showed
that the AP muffin produced an attenuated lipemic response, com-
pared with the AF meal. Berry et al. reported that muffins contain-
ing large particles of almond elicited plasma TAG concentrations
that were 74% lower (0–8 h iAUC) than for muffins containing
almond oil and defatted almond flour (Berry et al., 2008). The lar-
ger reduction in TAG iAUC reported by the Berry group (74%) com-
pared with the result from this study (38%) may be explained
perhaps by the greater lipid bioaccessibility of the almond oil
(100%) they used relative to that of the almond flour (49%) used
in our present study. However, this comparison should be treated
with caution due to the differences in participant characteristics
(healthy vs ileostomy subjects) and that in the current study data
from a single participant is reported. In the present investigation,
the lipemic response was also delayed following ingestion of the
AP meal compared with the AF meal. This observation is in agree-
ment with Burton-Freeman, Davis, and Schneeman (2004).
Despite having similar carbohydrate contents (88.5 g) the AF
muffin produced an attenuated, but prolonged plasma glucose
response, which may be due to more bioaccessible lipid being pre-
sent in the muffin matrix. This additional ‘free’ lipid may firstly
reduce the rate of gastric emptying and influence subsequent gut
hormone release, as previously reported by our group (Berry,
Lapsley, & Ellis, 2009). Secondly, amylose-lipid complexes may be
formed while mixing the batter and baking the muffins, particu-
larly in the AF muffins where there was more available lipid. These
complexes are hydrolysed more slowly by amylase than amylose
alone (Singh, Dartois, & Kaur, 2010).
The main strength of this study is the direct comparison of
in vitro and in vivo digestion of the same test meals with identical
compositions, but markedly different levels of lipid bioaccessibil-
ity. In vivomastication was used for both digestions, as in vitro sim-
ulation of the particle size reduction and salivary secretion
270 T. Grassby et al. / Journal of Functional Foods 37 (2017) 263–271associated with masticating complex foods in vivo is often unsatis-
factory (Cassady et al., 2009). As mastication is the main process by
which particle size is reduced (and therefore lipid bioaccessibility
increased) it was essential to use the same process for both models.
The main limitation of this study was the premature termination of
the in vivo study, resulting in data from only one participant being
available. The inherent resistance of these almond structures to
digestion seems to make them problematic for some individuals
with an ileostomy. We think that the blockages were caused
because the matrix was digested from around the almond particles,
allowing the hard angular particles to lock together to form a hard
plug which the movements within the intestine could not break
up. Therefore almonds and similar foods may be limited in their
potential use for future ileostomy studies. The data presented from
this one ileostomy participant, who did tolerate these meals, have
clearly shown that almond cellular integrity has a substantial
effect on lipid bioaccessibility in the small intestine. They also pro-
vide confirmation of suspected mechanisms behind the limited
digestibility of the nutrients in almonds, which will inform future
studies. It may be possible to repeat the study in ileostomy volun-
teers by substantially reducing the almond content of the meals to
a level the volunteers eat in their usual diets; however healthy vol-
unteers may be necessary for studies where the primary outcomes
dictate that large quantities of nuts be ingested. For future ileost-
omy studies, we would advise trialing any meals containing signif-
icant quantities of nuts prior to the main study.
In conclusion, this study confirmed that decreasing the size of
almond particles, and therefore reducing the proportion of intact
cells, increased the proportion of lipid digested by in vitro and
in vivo methods. A significant portion of the lipid remained sepa-
rated from the digestive enzymes by the physical barrier of intact
cell walls within the almond particles, even after 12 h of in vivo
digestion. The proportion of lipid digested seemed to be reflected
in the blood lipid, glucose and insulin responses, although the
structure and composition of the food matrix also had some influ-
ence on these results. The coupling of an in vivo mastication step
with the in vitro model showed good agreement with the in vivo
modeling of digestion, and in future studies this may provide a
cheaper alternative for studying complex food systems.Acknowledgements
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